High-dose-rate brachytherapy for localized prostate adenocarcinoma post abdominoperineal resection of the rectum and pelvic irradiation: Technique and experience

Brachytherapy

Volumn 8, Issue 4, 2009, Pages 339-344

  Jabbari, Siavash ^a   Hsu, I Chow ^a   Kawakami, Jun ^a   Weinberg, Vivian K ^b   Speight, Joycelyn L ^a   Gottschalk, Alexander R ^a   Roach III, Mack ^a   Shinohara, Katsuto ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Abdominoperineal resection; Brachytherapy; HDR; High dose rate; Prostate cancer

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; CATHETER; CATHETER COMPLICATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CYSTOSCOPY; ECHOGRAPHY; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HUMAN; MALE; MONOTHERAPY; PERITONEAL CATHETER; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; RADIATION DOSE FRACTIONATION; RECTUM ABDOMINOPERINEAL RESECTION; TRANSPERINEAL ULTRASOUND GUIDED BRACHYTHERAPY; TREATMENT FAILURE; TREATMENT PLANNING; URETHRA; URETHRA STRICTURE; URINARY FREQUENCY; URINARY TRACT OBSTRUCTION;

ADENOCARCINOMA; ADULT; AGED; BRACHYTHERAPY; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 70349436011     PISSN: 15384721     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brachy.2009.02.004     Document Type: Article

References (22)

1. Society AC. Estimated new cancer cases and deaths by sex for all sites, US, 2007 (2007), American Cancer Society, Atlanta
2. Moot A.R., Polglase A., Giles G.G., et al. Men with colorectal cancer are predisposed to prostate cancer. ANZ J Surg 73 (2003) 289-293
3. Murray S.K., Breau R.H., Guha A.K., et al. Spread of prostate carcinoma to the perirectal lymph node basin: Analysis of 112 rectal resections over a 10-year span for primary rectal adenocarcinoma. Am J Surg Pathol 28 (2004) 1154-1162
4. Engstrom P.F., Benson III A.B., Chen Y.J., et al. Rectal cancer clinical practice guidelines in oncology. J Natl Compr Canc Netw 3 (2005) 492-508
5. Shinohara K., Gulati M., Koppie T.M., et al. Transperineal prostate biopsy after abdominoperineal resection. J Urol 169 (2003) 141-144
6. Koutrouvelis P.G., Theodorescu D., Katz S., et al. Brachytherapy of prostate cancer after colectomy for colorectal cancer: Pilot experience. J Urol 173 (2005) 82-85 discussion 85-6
7. Kim Y., Hsu I.-C., and Pouliot J. Measurement of craniocaudal catheter displacement between fractions in computed tomography-based high dose rate brachytherapy of prostate cancer. J Appl Clin Med Phys 8 (2007) 1-13
8. Holloway C., Hsu I.-C., Albert M., et al. Prostate brachytherapy. In: Devlin P. (Ed). Brachytherapy applications and techniques (2007), Lippincott Williams and Wilkins Company, Philadelphia
9. Lee B., Shinohara K., Weinberg V., et al. Feasibility of high-dose-rate brachytherapy salvage for local prostate cancer recurrence after radiotherapy: The University of California-San Francisco experience. Int J Radiat Oncol Biol Phys 67 (2007) 1106-1112
10. Hsu I.C., Cabrera A.R., Weinberg V., et al. Combined modality treatment with high-dose-rate brachytherapy boost for locally advanced prostate cancer. Brachytherapy 4 (2005) 202-206
11. Consensus statement: guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel. Int J Radiat Oncol Biol Phys 37 (1997) 1035-1041
12. Roach III M., Hanks G., Thames Jr. H., et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 65 (2006) 965-974
13. Trotti A., Colevas A.D., Setser A., et al. CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol. 13 (2003) 176-181
14. Vargas C., Martinez A., Galalae R., et al. High-dose radiation employing external beam radiotherapy and high-dose rate brachytherapy with and without neoadjuvant androgen deprivation for prostate cancer patients with intermediate- and high-risk features. Prostate Cancer Prostatic Dis 9 (2006) 245-253
15. Niehoff P., Loch T., Nurnberg N., et al. Feasibility and preliminary outcome of salvage combined HDR brachytherapy and external beam radiotherapy (EBRT) for local recurrences after radical prostatectomy. Brachytherapy 4 (2005) 141-145
16. Grills I.S., Martinez A.A., Hollander M., et al. High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds. J Urol 171 (2004) 1098-1104
17. Martinez A.A., Pataki I., Edmundson G., et al. Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: A feasibility report. Int J Radiat Oncol Biol Phys 49 (2001) 61-69
18. Mullokandov E., and Gejerman G. Analysis of serial CT scans to assess template and catheter movement in prostate HDR brachytherapy. Int J Radiat Oncol Biol Phys 58 (2004) 1063-1071
19. Hoskin P.J., Bownes P.J., Ostler P., et al. High dose rate afterloading brachytherapy for prostate cancer: Catheter and gland movement between fractions. Radiother Oncol 68 (2003) 285-288
20. Damore S.J., Syed A.M., Puthawala A.A., et al. Needle displacement during HDR brachytherapy in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 46 (2000) 1205-1211
21. Van Gellekom M.P., Moerland M.A., Battermann J.J., et al. MRI-guided prostate brachytherapy with single needle method-A planning study. Radiother Oncol 71 (2004) 327-332
22. Cormack R.A., Kooy H., Tempany C.M., et al. A clinical method for real-time dosimetric guidance of transperineal 125I prostate implants using interventional magnetic resonance imaging. Int J Radiat Oncol Biol Phys 46 (2000) 207-214